UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Cardioprotection, attenuated systemic inflammation, and survival benefit of beta(1)-adrenoceptor blockade in severe sepsis in rats

Ackland, GL; Yao, ST; Rudiger, A; Dyson, A; Stidwill, R; Poputnikov, D; ... Gourine, AV; + view all (2010) Cardioprotection, attenuated systemic inflammation, and survival benefit of beta(1)-adrenoceptor blockade in severe sepsis in rats. CRIT CARE MED , 38 (2) 388 - 394. 10.1097/CCM.0b013e3181c03dfa.

Full text not available from this repository.

Abstract

Objective: To explore the hypothesis that beta-1 adrenoreceptor blockade may be protective through the attenuation of sympathetic hyperactivity and catecholaminergic inflammatory effects on cardiac and hepatic function.Design: Prospective, randomized, controlled study.Setting: Animal laboratory in a university medical center.Subjects: Male adult Wistar rats.Interventions: Peripheral beta(1)-adrenoceptor blockade through daily intraperitoneal injection (metoprolol, 100 mg.kg(-1); atenolol, 6 mg.kg(-1)) or central nervous system beta(1)-adrenoceptor blockade (intracerebroventricular metoprolol, 25 mu g) to achieve similar to 20% heart rate reduction in rats for 2 days before or after the induction of lethal endotoxemia, cecal ligation and puncture, or fecal peritonitis.Measurements and Main Results: Peripheral beta(1)-adrenoceptor blockade established for 2 days before lethal endotoxemia markedly improved survival in both metoprolol-treated (n = 16; log rank test, p = .002) and atenolol-treated (n = 15; p = .03) rats. Overall mortality in cecal ligation and puncture was similar between metoprolol (40%; n = 10) and saline (50%; n = 10) pretreatment (p = .56), but the median time to death was increased by 33 hrs in metoprolol-treated rats (p = .03). Metoprolol pretreatment reduced hepatic expression of proinflammatory cytokines and lowered plasma interleukin-6 (both p < .05). Myocardial protein expression of interleukin-18 and monocyte chemoattractant protein-1, key mediators of cardiac dysfunction in sepsis, were also reduced (p < .05). Peripheral beta(1)-adrenoceptor blockade commenced 6 hrs after lethal endotoxemia or fecal peritonitis did not improve survival. However, arterial blood pressure was preserved and left ventricular contractility restored similar to that found in nonseptic controls. Central nervous system beta(1)-adrenoceptor blockade (metoprolol) did not reduce plasma cytokines or mortality, despite enhancing parasympathetic tone.Conclusions: Peripheral beta(1)-adrenoceptor blockade offers anti-inflammatory and cardioprotective effects, with mortality reduction if commenced before a septic insult. Its role in sepsis should be explored further. (Crit Care Med 2010; 38:388-394)

Type:Article
Title:Cardioprotection, attenuated systemic inflammation, and survival benefit of beta(1)-adrenoceptor blockade in severe sepsis in rats
DOI:10.1097/CCM.0b013e3181c03dfa
Keywords:sepsis, adrenoreceptor, beta blocker, cytokines, inflammation, BETA-ADRENERGIC-BLOCKADE, TUMOR-NECROSIS-FACTOR, HEART-RATE-VARIABILITY, MYOCARDIAL DYSFUNCTION, NONCARDIAC SURGERY, CRITICALLY-ILL, NITRIC-OXIDE, HIGH-RISK, IN-VIVO, FAILURE
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Life Sciences > Biosciences (Division of) > Neuroscience, Physiology and Pharmacology
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of) > Clinical Physiology

Archive Staff Only: edit this record